EMORY UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
Sensorimotor Gating in Schizophrenia
Not Applicable
Completed
- Conditions
- Schizophrenia
- Interventions
- Behavioral: Acoustic startle testing
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- Emory University
- Target Recruit Count
- 531
- Registration Number
- NCT00561561
- Locations
- 🇺🇸
Atlanta VA Medical Center, Decatur, Georgia, United States
Low-dose Epinephrine Infusion Tests in Adolescent and Pediatric Patients
- First Posted Date
- 2007-10-24
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 7
- Registration Number
- NCT00548886
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
Phase 2
Completed
- Conditions
- Leukemia
- Interventions
- Biological: GM-CSFBiological: Interferon-α-2b
- First Posted Date
- 2007-10-24
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Emory University
- Target Recruit Count
- 15
- Registration Number
- NCT00548847
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Evaluating the Effects of Stress in Pregnancy
Completed
- Conditions
- Obsessive Compulsive Disorder (OCD)Generalized Anxiety DisorderPost-Traumatic Stress DisorderDepressionPanic Disorder
- First Posted Date
- 2007-09-05
- Last Posted Date
- 2013-11-20
- Lead Sponsor
- Emory University
- Target Recruit Count
- 1431
- Registration Number
- NCT00525226
- Locations
- 🇺🇸
Emory University Women's Mental Health Program, Atlanta, Georgia, United States
IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
Phase 4
Completed
- Conditions
- Tonic-clonic Seizure
- Interventions
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2013-12-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 158
- Registration Number
- NCT00510783
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2007-07-19
- Last Posted Date
- 2012-06-25
- Lead Sponsor
- Emory University
- Target Recruit Count
- 27
- Registration Number
- NCT00503750
- Locations
- 🇺🇸
Piedmont Hospital Research Institute, Atlanta, Georgia, United States
🇺🇸Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Modified Perfusion for Neonatal Aortic Arch Reconstruction
Not Applicable
Completed
- Conditions
- Aortic Arch Hypoplasia or Atresia
- Interventions
- Procedure: Modified Selective Cerebral Perfusion
- First Posted Date
- 2007-06-22
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- Emory University
- Target Recruit Count
- 14
- Registration Number
- NCT00490256
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Biomarkers for Detection of Brain Ischemia
Completed
- Conditions
- Congenital Disorders
- First Posted Date
- 2007-06-22
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Emory University
- Target Recruit Count
- 10
- Registration Number
- NCT00490295
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Speckle Tracking in Pediatric Patients
Completed
- Conditions
- Cardiomyopathy
- First Posted Date
- 2007-06-22
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Emory University
- Target Recruit Count
- 70
- Registration Number
- NCT00489957
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Predictors for Pulmonary Valve Replacement - Anatomic and Hemodynamic Using MRI
Completed
- Conditions
- Congenital Disorders
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2013-12-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 101
- Registration Number
- NCT00489788